Accent Capital Management »

Catalyst Pharmaceutical Partners shares owned by Accent Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Accent Capital Management from 13F filings

Historical chart of Accent Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Accent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Accent Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $10k 330 31.43

More positions owned by Accent Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
ALPHABET INC Class A Cl A Com (GOOG)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf (SPY)
Amazon (AMZN)
META PLATFORMS INC Class A Cl A Com (META)
Vanguard S&p 500 Etf idx (VOO)
ALPHABET INC Class C Cl C Com (GOOGL)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)
JPMorgan Chase & Co. (JPM)
Lam Research (LRCX)
Ge Vernova (GEV)
Tesla Motors (TSLA)

View all positions for Accent Capital Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners